ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
AtriCure Inc

AtriCure Inc (ATRC)

35,89
-0,14
( -0,39% )
Mis à jour : 16:13:25

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

Dernier
35,89
Prix Achat
35,88
Prix Vente
35,98
Volume échangé
9 906
35,765 Fourchette du Jour 36,075
18,94 Plage de 52 semaines 42,9999
Cap du marché
Clôture Veille
36,03
Ouverture
36,075
Dernière Transaction
46
@
35.94
Dernière heure de transaction
16:13:35
Volume financier
US$ 355 886
VWAP
35,9263
Volume moyen (3 m)
575 770
Actions en circulation
48 753 251
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-57,71
Bénéfice par action (BPA)
-0,62
Chiffre d'affairess
399,25M
Bénéfice net
-30,44M

À propos de AtriCure Inc

AtriCure Inc is a innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft T... AtriCure Inc is a innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. The company also offers a variety of minimally invasive ablation devices and access tools to facilitate the growing trend in less invasive cardiac and thoracic surgery. Geographically, it generates a majority of its revenue from the United States. Show more

Secteur
Surgical,med Instr,apparatus
Industrie
Surgical,med Instr,apparatus
Site Web
Siège social
Wilmington, Delaware, USA
Fondé
-
AtriCure Inc est coté dans le secteur Surgical,med Instr,apparatus de la NASDAQ avec le ticker ATRC. Le dernier cours de clôture d'AtriCure était de US$36,03. Au cours de la dernière année, les actions de AtriCure ont été négociées dans une fourchette de prix de US$ 18,94 à US$ 42,9999.

AtriCure compte actuellement 48 753 251 actions en circulation. La capitalisation boursière d'AtriCure est de US$1,76 milliard. AtriCure a un ratio cours/bénéfice (ratio PE) de -57.71.

ATRC Dernières nouvelles

AtriCure to Participate in the Piper Sandler 36th Annual Healthcare Conference

AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management...

AtriCure to Participate in the Stifel 2024 Healthcare Conference

AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management...

AtriCure Reports Third Quarter 2024 Financial Results

Worldwide revenue of $115.9 million – an increase of 17.9% year over year U.S. revenue of $95.5 million – an increase of 16.8% year over year Achieved 20% growth on revenues from open appendage...

AtriCure to Participate in the UBS Global Healthcare Conference

AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management...

AtriCure Announces Launch of cryoSPHERE MAX™ Probe for Post-Operative Pain Management

AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management...

AtriCure to Announce Third Quarter 2024 Financial Results

  AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain...

AtriCure a obtenu la certification de marquage CE pour la pince EnCompass®

Une approbation qui sert de nouveau vecteur de croissance à l'international pour AtriCure AtriCure, Inc. ( Nasdaq: ATRC ), leader en matière d'innovation pour les interventions chirurgicales et...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.49-1.3468938977536.3836.44534.2547005335.40019806CS
46.9724.100968188128.9238.3427.6473331833.86286404CS
1210.139.162466072125.7938.3425.2657577030.37343606CS
2613.6361.230907457322.2638.3418.9472620625.50280351CS
52-5.77-13.850216034641.6642.999918.9471091727.9941842CS
156-41.78-53.791682760477.6779.62518.9443461736.87571618CS
2606.8523.5881542729.0489.1818.9439976542.29509748CS

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
SKKSKK Holdings Limited
US$ 10,86
(138,16%)
2,68M
WORXSCWorx Corporation
US$ 2,15
(119,39%)
80,83M
CRNCCerence Inc
US$ 4,50
(59,57%)
7,99M
SPAISafe Pro Group Inc
US$ 4,3999
(37,50%)
34M
CDTConduit Pharmaceuticals Inc
US$ 0,1243
(34,67%)
405,44M
PYXSPyxis Oncology Inc
US$ 2,0101
(-47,38%)
6,59M
KURAKura Oncology Inc
US$ 10,02
(-37,02%)
5,21M
BLRXBioLineRx Ltd
US$ 0,3805
(-30,21%)
4,32M
AGFYAgrify Corporation
US$ 27,2093
(-29,80%)
260,84k
SHOTWSafety Shot Inc
US$ 0,11
(-26,67%)
1 000
CDTConduit Pharmaceuticals Inc
US$ 0,1243
(34,67%)
405,44M
AKTSAkoustis Technologies Inc
US$ 0,0995
(14,24%)
160,04M
NVDANVIDIA Corporation
US$ 144,33
(-1,07%)
126,36M
WORXSCWorx Corporation
US$ 2,15
(119,39%)
80,83M
ELABElevai Labs Inc
US$ 0,02015
(-5,84%)
60,3M
Aucune Discussion Trouvée
Ajouter une Discussion